Frontpage » Another Round In $Billion Vaccine Patent Fights

Another Round In $Billion Vaccine Patent Fights

pills-falling-from-pill-bottle-on-blue-background-with-copyspace-picture-id1035982466

November 9, 2022

Arbutus Biopharma and Genevant Sciences sued Moderna last February, alleging infringement of Covid vaccine delivery technology. In May, Moderna filed a motion to dismiss, arguing that the government should defend against the claims because the company was simply providing doses under a federal contract. U.S. District Judge Mitchell Goldberg dismissed the motion, ruling that Moderna failed to prove its point. A Moderna spokesperson called the decision “procedural,” and said the company was still confident in its argument, and also in “proving that there was no infringement by Moderna of the Arbutus patents.” Moderna is also in court with RNA specialist Alnylam for alleged infringement, and has filed a lawsuit against Pfizer and BioNTech for infringing on its patents. The stakes in all these suits are huge because pandemic shots have generated tens of billions of dollars in revenue for big pharma.

Share this post:

Find this article interesting?

Sign up for more with a complimentary subscription to Today’s General Counsel magazine.